check
Improving cognition and function in cancer survivors | Computerized Neurotherapy lab

Improving cognition and function in cancer survivors

Between 30-50% of cancer survivors report cognitive decline, which may result from the malignancy itself or is a by-product of treatments (chemotherapy, radiation). The current pilot study will test the effectiveness of a combined treatment approach, which includes remote cognitive training and functional treatment using tele-rehabilitation. We will assess cognitive function, quality of life and daily function in adult cancer survivors.

 

Collaborators: Dr Yafit Gilboa (Psychology); Dr. Chen Makranz (Oncology, Hadassah)

Funding: Israeli Cancer Association

ICRF Brause Family Initiative for Quality of Life